158
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Circular RNA CircTTBK2 Facilitates Non-Small-Cell Lung Cancer Malignancy through the miR-873-5p/TEAD1/DERL1 Axis

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & show all
Pages 931-949 | Received 21 Nov 2021, Accepted 11 Apr 2022, Published online: 02 Aug 2022

References

  • Bray F , FerlayJ , SoerjomataramIet al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin.68, 394–424 (2018).
  • Reck M , PopatS , ReinmuthNet al. Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol.25(Suppl. 3), iii27–39 (2014).
  • Chen W , ZhengR , BaadePDet al. Cancer statistics in China, 2015. CA Cancer J. Clin.66, 115–132 (2016).
  • Siegel RL , MillerKD , JemalA. Cancer statistics, 2016. CA Cancer J. Clin.66, 7–30 (2016).
  • Beermann J , PiccoliMT , ViereckJ , ThumT. Non-coding RNAs in development and disease: background, mechanisms, and therapeutic approaches. Physiol. Rev.96, 1297–1325 (2016).
  • Mahood G . Tobacco lawsuits hold public health potential. Can Nurse110, 42 (2014).
  • Jiang MM , MaiZT , WanSZet al. Microarray profiles reveal that circular RNA hsa_circ_0007385 functions as an oncogene in non-small cell lung cancer tumorigenesis. J. Cancer Res. Clin. Oncol.144, 667–674 (2018).
  • Zhu X , WangX , WeiSet al. hsa_circ_0013958: a circular RNA and potential novel biomarker for lung adenocarcinoma. FEBS J.284, 2170–2182 (2017).
  • Zheng J , LiuX , XueYet al. TTBK2 circular RNA promotes glioma malignancy by regulating miR-217/HNF1beta/Derlin-1 pathway. J. Hematol. Oncol.10, 52 (2017).
  • Han C , WangS , WangH , ZhangJ. Knockdown of circ-TTBK2 inhibits glioma progression by regulating miR-1283 and CHD1. Cancer Manag. Res.12, 10055–10065 (2020).
  • Yuan DH , ZhaoJ , ShaoGF. Circular RNA TTBK2 promotes the development of human glioma cells via miR-520b/EZH2 axis. Eur. Rev. Med. Pharmacol. Sci.23, 10886–10898 (2019).
  • Zhu Y , ZhangX , QiMet al. miR-873-5p inhibits the progression of colon cancer via repression of tumor suppressor candidate 3/AKT signaling. J. Gastroenterol. Hepatol.34, 2126–2134 (2019).
  • Wang Z , LiuW , WangC , AiZ. miR-873-5p inhibits cell migration and invasion of papillary thyroid cancer via regulation of CXCL16. Onco Targets Ther.13, 1037–1046 (2020).
  • Li G , XuY , WangSet al. MiR-873-5p inhibits cell migration, invasion and epithelial-mesenchymal transition in colorectal cancer via targeting ZEB1. Pathol. Res. Pract.215, 34–39 (2019).
  • Hu X , MuY , WangJ , ZhaoY. LncRNA TDRG1 promotes the metastasis of NSCLC cell through regulating miR-873-5p/ZEB1 axis. J. Cell Biochem. (2019).
  • Yu MH , ZhangW. TEAD1 enhances proliferation via activating SP1 in colorectal cancer. Biomed. Pharmacother.83, 496–501 (2016).
  • Fan J , TianL , HuangSet al. Derlin-1 promotes the progression of human hepatocellular carcinoma via the activation of AKT Pathway. Onco Targets Ther.13, 5407–5417 (2020).
  • Dong Y , HeD , PengZet al. Circular RNAs in cancer: an emerging key player. J. Hematol. Oncol.10, 2 (2017).
  • Bowie E , GoetzSC. TTBK2 and primary cilia are essential for the connectivity and survival of cerebellar Purkinje neurons. Elife9 (2020).
  • Chen L , NanA , ZhangNet al. Circular RNA 100146 functions as an oncogene through direct binding to miR-361-3p and miR-615-5p in non-small cell lung cancer. Mol. Cancer18, 13 (2019).
  • Li B , ZhuL , LuC , WangCet al. circNDUFB2 inhibits non-small cell lung cancer progression via destabilizing IGF2BPs and activating anti-tumor immunity. Nat. Commun.12, 295 (2021).
  • Fu Y , HuangL , TangH , HuangR. hsa_circRNA_012515 is highly expressed in NSCLC patients and affects its prognosis. Cancer Manag. Res.12, 1877–1886 (2020).
  • Hansen TB , JensenTI , ClausenBHet al. Natural RNA circles function as efficient microRNA sponges. Nature495, 384–388 (2013).
  • Lasda E , ParkerR. Circular RNAs: diversity of form and function. RNA20, 1829–1842 (2014).
  • Wei S , ZhengY , JiangYet al. The circRNA circPTPRA suppresses epithelial-mesenchymal transitioning and metastasis of NSCLC cells by sponging miR-96-5p. EBioMedicine44, 182–193 (2019).
  • Zhang PF , PeiX , LiKSet al. Circular RNA circFGFR1 promotes progression and anti-PD-1 resistance by sponging miR-381-3p in non-small cell lung cancer cells. Mol. Cancer18, 179 (2019).
  • Wang L , JiangF , MaF , ZhangB. MiR-873-5p suppresses cell proliferation and epithelial-mesenchymal transition via directly targeting Jumonji domain-containing protein 8 through the NF-kappaB pathway in colorectal cancer. J. Cell Commun. Signal13, 549–560 (2019).
  • Luo J , ZhuH , JiangHet al. The effects of aberrant expression of LncRNA DGCR5/miR-873-5p/TUSC3 in lung cancer cell progression. Cancer Med.(2018).doi:10.1002/cam4.1566
  • Liu R , JagannathanRet al. Tead1 is essential for mitochondrial function in cardiomyocytes. Am. J. Physiol. Heart Circ. Physiol.319, H89–H99 (2020).
  • Liu R , JagannathanR , LiFet al. Tead1 is required for perinatal cardiomyocyte proliferation. PLOS ONE14, e0212017 (2019).
  • Wen T , LiuJ , HeXet al. Transcription factor TEAD1 is essential for vascular development by promoting vascular smooth muscle differentiation. Cell Death Differ.26, 2790–2806 (2019).
  • Zhou Y , HuangT , ZhangJet al. TEAD1/4 exerts oncogenic role and is negatively regulated by miR-4269 in gastric tumorigenesis. Oncogene36, 6518–6530 (2017).
  • Yang F , WeiK , QinZet al. MiR-598 suppresses invasion and migration by negative regulation of Derlin-1 and epithelial-mesenchymal transition in non-small cell lung cancer. Cell Physiol. Biochem.47, 245–256 (2018).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.